Skip to main content
. 2021 Mar 26;14:50. doi: 10.1186/s13045-021-01063-9

Table 2.

Selpercatinib safety overview

TRAEs with selpercatinib
(LOXO-292)
LIBRETTO-001 Safety Database*
(N = 531)
Any Grade 3
Dry mouth 27
Diarrhea 16 1
Hypertension 18 8
AST increased 22 4
ALT increased 21 6
Fatigue 14  < 1
Constipation 11  < 1
Headache 7  < 1
Nausea 8  < 1
Peripheral edema 10
Creatinine increased 10

TRAEs, Treatment related adverse events

*Includes all tumor types (eg, NSCLC, MTC, Thyroid, etc.)